Auto-disable syringes for immunization: issues in technology transfer
Lloyd, J.S.; Milstien, J.B.
Bulletin of the World Health Organization 77(12): 1001-1007
1999
ISSN/ISBN: 0042-9686 PMID: 10680248 Document Number: 276253
This article examines the factors influencing technology transfer, including feasibility, corporate interest, cost, quality assurance, intellectual property considerations, and probable time frames for implementing the use of auto-disable (AD) syringes. WHO and its partners recommend the use of AD syringes, "bundled" with a supply of vaccines when donor dollars are used in all mass immunization campaigns, and also strongly advocate their use in routine immunization programs. Due to the relatively high price of AD syringes, WHO's Technical Network for Logistics in Health recommends that activities must be initiated to encourage the transfer of production technology for these syringes as a means of promoting their use and enhancing its access to it. Technology transfer activities are likely to be complex and difficult and may not result in lower prices for syringes. Guidelines are offered on technology transfer initiatives for AD syringes to ensure the quality of the product, the reliability of the supply, and the feasibility of the technology transfer activity.